Air Global PLC, the Dubai-headquartered maker of Al Fakher hookah molasses that listed on Nasdaq through a May 2026 business combination with Cantor Equity Partners III, is being priced not on its traditional shisha franchise but on three post-listing developments that management has placed in front of the market within its first three months as a public company. The shares ended the week of August 14 at $7.46, roughly a fifth below the $10.49 redemption value that anchors the company's forward purchase agreement, which tells investors what the pre-listing SPAC holders believed the equity was worth versus what the public market currently concedes.
The underlying business prints franchise-quality economics. For the fiscal year ended December 31, 2025, the most recent period with audited results, Air generated $399.7 million of revenue, $139.3 million of adjusted EBITDA on a 34.8 percent adjusted margin, and $46.8 million of net income, with the adjusted EBITDA figure up 7.5 percent year on year. The centralized question for the equity is not whether the hookah cash engine works, because it plainly does; it is whether that engine, burdened by $268 million of net debt carried into the listing, can fund three simultaneous commitments: the impending $52.45 million repurchase of five million shares from Harraden Circle at $10.49, a $20 million strategic stake in the vaporization technology firm Greentank Innovations, and a still-unsigned United States pathway for its Crown Switch vape through the Food and Drug Administration's pre-market authorization process.
The single load-bearing risk is the balance sheet. Net debt of $268 million against roughly $1.2 billion of market value, together with a forward purchase agreement that caps the stock's near-term upside, leaves thin margin for error if the device strategy ramps slower than the financing calendar demands. The falsifiable clock is the August 24 extraordinary general meeting, where shareholders vote on the Harraden repurchase and a buyback authorization covering up to 20 percent of the share count annually through 2031, followed by the interim financial report for the first half of 2026 that has not yet reached the U.S. record; those two events test whether the company can execute its liability management while still funding growth.